Viewing Study NCT01297192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-04-26 @ 8:56 PM
Study NCT ID: NCT01297192
Status: COMPLETED
Last Update Posted: 2013-07-29
First Post: 2011-02-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Pharmacokinetics of Mirabegron View
Keywords:

Keywords

Keyword Brief Keyword Text View
None YM178 View
None Mirabegron View
None DDI View
None Phase I View
None Solifenacin View
None Pharmacokinetics View
None Pharmacokinetics of mirabegron View